Other events, such as cardiomyopathy, myocardial fibrosis, myocarditis, and acute heart failure, were also reported in single anti-CTLA-4 or anti-PD-1 treatment (54), and lethal myocarditis accompanying with myositis was seen in combinatorial treatment (55), although such cases are rare. This evidence concerns the gene CTLA4 and myocarditis.